Xiong Huang

ORCID: 0009-0002-8413-2803
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electroconvulsive Therapy Studies
  • Treatment of Major Depression
  • Transcranial Magnetic Stimulation Studies
  • Bipolar Disorder and Treatment
  • Traditional Chinese Medicine Studies
  • Neurological disorders and treatments
  • Schizophrenia research and treatment
  • Tryptophan and brain disorders
  • Nuclear Engineering Thermal-Hydraulics
  • Epilepsy research and treatment
  • Anesthesia and Sedative Agents
  • Complexity and Algorithms in Graphs
  • Combustion and Detonation Processes
  • Big Data Technologies and Applications
  • Hernia repair and management
  • Functional Brain Connectivity Studies
  • Computability, Logic, AI Algorithms
  • Neurological Disorders and Treatments
  • Advanced Computational Techniques and Applications
  • Safety and Risk Management
  • Ginkgo biloba and Cashew Applications
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Teaching and Learning Programming
  • E-commerce and Technology Innovations
  • Risk and Safety Analysis

Guangzhou Medical University
2014-2025

Shanghai Children's Hospital
2014-2024

Shanghai Jiao Tong University
2014-2024

Zhejiang University of Finance and Economics
2023

Commercial Aircraft Corporation of China (China)
2023

Nankai University
2021

Guangzhou Psychiatric Hospital
2014-2020

North China Electric Power University
2015-2020

Jiaxing University
2008-2018

Guangxi Medical University
2016

Development of successful formulations for poorly water-soluble drugs remains a longstanding critical and challenging issue in cancer therapy. The stearic acid-g-chitosan oligosaccharide (CSO-SA) micelles have been presented as potential candidates intracellular antitumour agent delivery carrier. Herein, podophyllotoxin (PPT) loaded CSO-SA (CSO-SA/PPT) were prepared by dialysis method. drug encapsulation efficiency could reach higher level, the micellar size zeta increased with increasing...

10.3109/02652048.2011.621551 article EN Journal of Microencapsulation 2012-01-01

Purpose Because of differences in therapy for first-time perianal abscess, a wide range recurrences and/or development fistula-in-ano (RF) rates have been reported. The indication determining when surgical intervention is needed remains obscure and controversial. This retrospective study sought to compare outcomes conservative treatment with those after incision drainage (ID) determine the optimal time intervention. Methods A total 697 patients abscess were included this study. median...

10.1055/s-0037-1603092 article EN European Journal of Pediatric Surgery 2017-05-31

Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) is a safe, effective, and novel technique that currently being used in electroconvulsive therapy (ECT). This study aimed to summarize the clinical practices of THRIVE use ECT aid physicians institutions implementing best practice guidelines for ECT. Thus, we reviewed current literature presented our consensus on application daily practice. provides information regarding ECT, including its safety, effectiveness,...

10.5152/alphapsychiatry.2024.231463 article EN ALPHA PSYCHIATRY 2024-05-02

Background Electroconvulsive therapy (ECT)-induced fever can significantly affect patient experience, treatment adherence, and the course of treatment. However, little is known about prevalence ECT-induced its associated risk factors in patients with major mental disorders (MMD). Methods This retrospective, case-control study included 113 cases 226 age-matched controls (1:2). The case group comprised who exhibited an axillary temperature ≥37.5°C (99.5°F) at least once within 24 hours...

10.3389/fpsyt.2024.1530533 article EN cc-by Frontiers in Psychiatry 2025-01-24

Ketamine and propofol have become increasingly popular in electroconvulsive therapy (ECT) anaesthesia. This study was conducted to examine whether changes serum levels of brain-derived neurotrophic factor (BDNF) are associated with the antidepressant effects ketofol, a combination ketamine propofol, ECT for patients treatment-resistant depression (TRD).Thirty TRD (18-65 years) were enrolled underwent eight sessions (0.5 mg/kg) plus (ketofol). Symptom severity monitored using 17-item Hamilton...

10.2147/ndt.s248190 article EN cc-by-nc Neuropsychiatric Disease and Treatment 2020-04-01
Coming Soon ...